About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Landscape in HR+, HER2- MBC
Treatment Landscape in HR+, HER2- MBC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
N
Case Studies Discussion of Patients with HR+/HER2- mBC
By
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
FEATURING
Natasha Hunter
By
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
FEATURING
Natasha Hunter
122 views
March 3, 2023
0 Comments
Login to view comments.
Click here to Login
Treatment Landscape in HR+, HER2- MBC
30:46
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"
Feat.
S. Tolaney,
H. Rugo
17:20
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…
Feat.
P. Tarantino
08:40
PrecisCa
Managing Common Toxicities From CDK4/6i
Feat.
E. Shonkwiler
08:51
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Effects of Ovarian Ablation or Suppressio…
Feat.
R. Gray
05:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial -…
Feat.
C. Becherini,
L. Livi
06:55
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Comparative OS of Pts in Trials of CKD4/6…
Feat.
C. Kappel
13:35
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Tri…
Feat.
N. El Saghir
19:21
Abirami Sivapiragasam
Sequencing Treatment Options for HR+ mBC
12:44
SABCS 2022 Conference Coverage
SABCS 2022 Primary Results From the Randomized Phase II RIGHT Choice…
Feat.
Y. Lu
19:12
Penn Medicine Abramson Cancer Center
Updates in HR+ mBC
Feat.
I. Makhlin
17:31
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Case Studies Discussion of Patients with HR+/HER2- mBC
Feat.
N. Hunter
26:03
Total Health
HR+ mBC: Optimizing Endocrine Therapy
Feat.
J. O'Shaughnessy
20:16
University of Colorado Cancer Center
Updated NCCN Guidelines for HR+/HER2- mBC: Treatment Options in 1L S…
Feat.
V. Borges
19:02
Denise Yardley
Phase III Pooled MONALEESA Safety & Efficacy Data in HR+/HER2- m…
10:43
Ahmad Awada
Recent Development in the Treatment of HR+/HER2- mBC
22:17
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
Administration, Safety, and Dosing of Ribociclib for ER+/HER2- mBC
Feat.
J. Lauria
08:31
Neelam Desai
Comparing the Efficacy Data of CDK4/6i in HR+/HER2- mBC
13:35
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The RIGHT Choice Trial - 1L Ribociclib + E…
Feat.
H. Azim
12:08
West Cancer Center
Patient Selection for CDK4/6i in HR+/HER2- Advanced BC
Feat.
G. Vidal